Maximus (MMS) to Release Earnings on Thursday

Maximus (NYSE:MMS - Get Free Report) is projected to announce its Q2 2025 earnings results before the market opens on Thursday, May 8th. Analysts expect the company to announce earnings of $1.37 per share and revenue of $1.29 billion for the quarter. Maximus has set its FY 2025 guidance at 5.900-6.200 EPS.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, analysts expect Maximus to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Maximus Price Performance

NYSE:MMS traded up $0.26 during mid-day trading on Tuesday, hitting $66.51. 66,858 shares of the company's stock traded hands, compared to its average volume of 556,755. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The company has a market cap of $3.76 billion, a PE ratio of 14.33 and a beta of 0.61. The firm's 50 day simple moving average is $67.64 and its 200 day simple moving average is $73.41. Maximus has a 1 year low of $63.77 and a 1 year high of $93.97.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.80%. Maximus's dividend payout ratio is presently 25.81%.

Insider Activity at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.